Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Stockholder Note Receivable
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance (in shares) at Dec. 31, 2020   145,196,000        
Balance at Dec. 31, 2020 $ 1,481,413 $ 1,452 $ 1,569,905 $ (15,000) $ (71,714) $ (3,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (274,599)       (274,599)  
Other comprehensive income 323         323
Share-based compensation $ 2,924   2,924      
Stock option exercises (in shares) 0          
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards $ 3,844   3,844      
Cancellation of stockholder note receivable 3,645   (11,355) 15,000    
Dividends on preferred stock (16,414)   (16,414)      
Balance (in shares) at Sep. 30, 2021   145,196,000        
Balance at Sep. 30, 2021 1,201,136 $ 1,452 1,548,904 0 (346,313) (2,907)
Balance (in shares) at Jun. 30, 2021   145,196,000        
Balance at Jun. 30, 2021 1,249,669 $ 1,452 1,564,591 (15,000) (300,871) (503)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (45,442)       (45,442)  
Other comprehensive income (2,404)         (2,404)
Share-based compensation $ 1,794   1,794      
Stock option exercises (in shares) 0          
Cancellation of stockholder note receivable $ 3,645   (11,355) 15,000    
Dividends on preferred stock (6,126)   (6,126)      
Balance (in shares) at Sep. 30, 2021   145,196,000        
Balance at Sep. 30, 2021 $ 1,201,136 $ 1,452 1,548,904 $ 0 (346,313) (2,907)
Balance (in shares) at Dec. 31, 2021 193,060,000 193,060,000        
Balance at Dec. 31, 2021 $ 2,091,392 $ 1,931 2,743,560   (651,083) (3,016)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (15,519)       (15,519)  
Other comprehensive income (7,339)         (7,339)
Share-based compensation $ 33,214   33,214      
Stock option exercises (in shares) 300,000 309,000        
Stock option exercises $ 3,190 $ 3 3,187      
Equity issuance costs (270)   (270)      
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   622,000        
Issuance of common shares in connection with the vesting of restricted stock units 0 $ 6 (6)      
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards $ 505   505      
Balance (in shares) at Sep. 30, 2022 193,991,000 193,991,000        
Balance at Sep. 30, 2022 $ 2,105,173 $ 1,940 2,780,190   (666,602) (10,355)
Balance (in shares) at Jun. 30, 2022   193,796,000        
Balance at Jun. 30, 2022 2,078,657 $ 1,938 2,772,393   (691,334) (4,340)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 24,732       24,732  
Other comprehensive income (6,015)         (6,015)
Share-based compensation $ 5,803   5,803      
Stock option exercises (in shares) 200,000 195,000        
Stock option exercises $ 1,996 $ 2 1,994      
Balance (in shares) at Sep. 30, 2022 193,991,000 193,991,000        
Balance at Sep. 30, 2022 $ 2,105,173 $ 1,940 $ 2,780,190   $ (666,602) $ (10,355)